LONDON, July 1, 2014 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom
Today, Earnings Review released its analysts' notes regarding Spectris plc (LON: SXS), Genesis Emerging Markets Fund Limited (LON: GSS), Jardine Lloyd Thompson Group plc (LON: JLT), A.G. Barr plc (LON: BAG) and Berkeley Group Holdings PLC (LON: BKG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://earnings-review.com/4304-100free.
Spectris plc Analyst Notes
On June 18, 2014, Spectris plc (Spectris) announced that the Company has acquired Canadian company La Corporation Scientifique Claisse (Claisse), engaged in sample preparation for atomic spectroscopy (including X-ray) analysis for an undisclosed sum. Spectris informed that Claisse will become part of the Materials Analysis segment and will be integrated into PANalytical, combining two leaders in fusion and X-Ray Fluorescence (XRF) analysis. Eoghan O'Lionaird, Business Group Director, Spectris, said, "Claisse is a strong strategic addition to Spectris' Materials Analysis segment as it deepens our presence within the sample preparation market. Claisse is renowned for its innovation and fusion technology leadership, and we are confident that the market will benefit from PANalytical's support of Claisse's continued product and application development plans. We believe there is a cultural fit with PANalytical, and that the combined capabilities will create significant value for XRF customers, as well as increasing PANalytical's resilient revenues." The full analyst notes on Spectris are available to download free of charge at:
Genesis Emerging Markets Fund Limited Analyst Notes
On June 25, 2014, Morningstar reported that Genesis Emerging Markets Fund Limited's (Genesis) Net Asset Value (NAV) as on June 24, 2014 was 579.81 per share. Genesis is a Guernsey-based closed-ended investment Company. The Company's investment objective is to provide shareholders with a diversified means of investing in developing countries and immature stock markets. The full analyst notes on Genesis are available to download free of charge at:
Jardine Lloyd Thompson Group plc Analyst Notes
On June 25, 2014, Jardine Lloyd Thompson Group plc (JLT) announced that the Company has filed an application with the UK Listing Authority and The London Stock Exchange for a block listing of 100,000 ordinary shares of five pence each under the JLT's Share Option Scheme, to trade on The London Stock Exchange and to be admitted to The Official List. JLT informed that the aforesaid shares shall rank equally with the existing issued shares of the Company. The full analyst notes on JLT are available to download free of charge at:
A.G. Barr plc Analyst Notes
On May 30, 2014, A.G. Barr plc (A.G. Barr) - the soft drinks group, announced that the Company is planning to invest £4 million for the next phase of expansion of its Milton Keynes facility. After the successful completion of Phase I of investment and following a comprehensive review of existing operations, A.G. Barr now plans to invest in high speed carton production capability at Milton Keynes. According to A.G. Barr, the new carton production facility will support the current demand and provide future capacity and flexibility for this core packaging format, principally associated with the Rubicon and KA juice drink brands. The Company has a current in-house carton capacity located at its Tredegar site in Wales and plans to close its existing carton facility at the end of January 2015, subject to employee consultation. The full analyst notes on A.G. Barr are available to download free of charge at:
Berkeley Group Holdings PLC Analyst Notes
On June 18, 2014, Berkeley Group Holdings PLC (Berkeley Group) released its preliminary FY 2014 financial results (period ended April 30, 2014). The Company reported FY 2014 revenue of £1.6 billion, up 18.1% YoY. During the year, the Company's operating profit improved 33.8% YoY to £374.8 million. The Company's FY 2014 profit after tax (PAT) came in at £292.9 million or 188.4 pence per diluted share, compared to a PAT of £209.7 million or 140.3 pence per diluted share in FY 2013. The Company's Board has declared an interim dividend of 90 pence per share payable on September 26, 2014 to shareholders of record on August 22, 2014. The Board will seek the approval of shareholders at the Annual General Meeting on September 1, 2014. Berkeley stated that it is on course to meet its commitment to return over £1.7 billion to shareholders by 2021. The full analyst notes on Berkeley are available to download free of charge at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] earnings-review.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] earnings-review.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] earnings-review.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Earnings Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Earnings Review in this article or report according to the procedures outlined by Earnings Review. Earnings Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Earnings Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Earnings Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Earnings Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Earnings Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Earnings Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Earnings Review